28 | N- propyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (PPTP)IBA
01/2017
-
12/2007 |
4 | Vincristine (Oncovin)FDA LinkGeneric
09/2015
-
12/2007 |
4 | ProdrugsIBA
09/2015
-
01/2011 |
3 | MLN 8237IBA
01/2019
-
07/2010 |
3 | navitoclaxIBA
01/2016
-
06/2008 |
3 | PR-104IBA
09/2015
-
01/2011 |
2 | Dexamethasone (Maxidex)FDA LinkGeneric
09/2015
-
01/2010 |
2 | Biomarkers (Surrogate Marker)IBA
09/2015
-
09/2014 |
2 | Asparaginase (Elspar)FDA Link
09/2015
-
01/2012 |
2 | PR-104AIBA
09/2015
-
09/2011 |
2 | talazoparibIBA
02/2015
-
01/2015 |
2 | Temozolomide (Temodar)FDA LinkGeneric
02/2015
-
05/2013 |
2 | Proteins (Proteins, Gene)FDA Link
06/2012
-
07/2008 |
2 | Topotecan (Hycamtin)FDA LinkGeneric
02/2012
-
05/2010 |
2 | Sirolimus (Rapamycin)FDA Link
01/2010
-
04/2008 |
1 | Focal Adhesion Protein-Tyrosine KinasesIBA
01/2017 |
1 | PND 1186IBA
01/2017 |
1 | CBLC137IBA
01/2017 |
1 | Chimeric Antigen ReceptorsIBA
11/2016 |
1 | AntigensIBA
11/2016 |
1 | purineIBA
03/2016 |
1 | Exportin 1 ProteinIBA
02/2016 |
1 | selinexorIBA
02/2016 |
1 | birinapantIBA
01/2016 |
1 | venetoclaxIBA
01/2016 |
1 | Mechlorethamine (Nitrogen Mustard)FDA Link
09/2015 |
1 | Phosphates (Orthophosphate)IBA
09/2015 |
1 | EstersIBA
09/2015 |
1 | BAL27862IBA
06/2015 |
1 | lisavanbulinIBA
06/2015 |
1 | Poly(ADP-ribose) Polymerase InhibitorsIBA
02/2015 |
1 | EnzymesIBA
02/2015 |
1 | Janus Kinase InhibitorsIBA
02/2015 |
1 | AZD 1480IBA
02/2015 |
1 | Janus KinasesIBA
02/2015 |
1 | Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2015 |
1 | Liposomes (Liposome)IBA
01/2015 |
1 | CPX-351IBA
01/2015 |
1 | Cytarabine (Cytosar-U)FDA LinkGeneric
01/2015 |
1 | Daunorubicin (Cerubidine)FDA LinkGeneric
01/2015 |
1 | sapanisertibIBA
08/2014 |
1 | nirogacestatIBA
08/2014 |
1 | quisinostatIBA
02/2014 |
1 | Polo-Like Kinase 1IBA
01/2014 |
1 | BI 6727IBA
01/2014 |
1 | eribulinFDA Link
08/2013 |
1 | Antimitotic AgentsIBA
08/2013 |
1 | DNA (Deoxyribonucleic Acid)IBA
05/2013 |
1 | XL147IBA
05/2013 |
1 | Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
05/2013 |
1 | coltuximab ravtansineIBA
04/2013 |
1 | Immunoconjugates (Immunoconjugate)IBA
04/2013 |
1 | RG7112IBA
04/2013 |
1 | Maytansine (Maitansine)IBA
04/2013 |
1 | dinaciclibIBA
12/2012 |
1 | SGI 1776IBA
10/2012 |
1 | MK 2206IBA
09/2012 |
1 | pevonedistatIBA
08/2012 |
1 | JNJ 26854165IBA
08/2012 |
1 | (2,4- dihydroxy- 5- isopropylphenyl)- (5- (4- methylpiperazin- 1- ylmethyl)- 1,3- dihydroisoindol- 2- yl)methanoneIBA
07/2012 |
1 | GSK923295IBA
06/2012 |
1 | KinesinsIBA
06/2012 |
1 | 2,2- dimethyl- N- (6- oxo- 6,7- dihydro- 5H- dibenzo(b,d)azepin- 7- yl)- N'- (2,2,3,3,3- pentafluoropropyl)malonamideIBA
05/2012 |
1 | LCL161IBA
04/2012 |
1 | Genz-644282IBA
02/2012 |
1 | Messenger RNA (mRNA)IBA
02/2012 |
1 | Mechanistic Target of Rapamycin Complex 2IBA
02/2012 |
1 | Mechanistic Target of Rapamycin Complex 1IBA
02/2012 |
1 | (5- (2,4- bis((3S)- 3- methylmorpholin- 4- yl)pyrido(2,3- d)pyrimidin- 7- yl)- 2- methoxyphenyl)methanolIBA
02/2012 |
1 | AnthracyclinesIBA
01/2012 |
1 | GlucocorticoidsIBA
01/2012 |
1 | Aurora Kinase AIBA
11/2011 |
1 | Lenalidomide (CC 5013)FDA Link
10/2011 |
1 | Aldo-Keto ReductasesIBA
09/2011 |
1 | Aldo-Keto Reductase Family 1 Member C3IBA
09/2011 |
1 | Oxidoreductases (Dehydrogenase)IBA
09/2011 |
1 | SpermineIBA
08/2011 |
1 | PolyaminesIBA
08/2011 |